Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Albendazole Plus Praziquantel for Subarachnoid Cysticercosis
NCT02947581Phase 3Terminated
- Sponsor
- Universidad Peruana Cayetano Heredia
- Start
- Nov 2016
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of praziquantel in neurocysticercosis (NCC), sponsored by Universidad Peruana Cayetano Heredia. Started Nov 2016; status: terminated.
02
Drugs
praziquantel
03
Conditions
neurocysticercosis (NCC)
Beyond the preview
Go deeper on NCT02947581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02947581.